DocDollars

Leo Pharma As

Denmark · Reporting entity ID 100000005663

Total reported 2019–2025
$30.5M
#236 of 2,960 reporting companies — 0% of all reported industry payments
$2.15M in general payments across 1,567 records, plus $28.3M in research funding across 4,124 records.

How it breaks down

General payments $2,153,876
Research funding $28,339,886

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Leo Pharma As reported $30.5M to US doctors and teaching hospitals from 2019 to 2025, ranking #236 of 2,960 reporting companies. 93% of that was research funding and 7% general payments such as consulting, speaking, food and travel. 1,567 general payment records and 4,124 research records were filed.

Common questions about Leo Pharma As

How much has Leo Pharma As paid US doctors?

Leo Pharma As reported $30,493,763 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,153,876 in general payments, $28,339,886 in research funding.

How does Leo Pharma As rank among drug and device companies?

It ranks #236 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Leo Pharma As mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.